Primary tabs

A Live Recombinant Attenuated Salmonella Anti-Pneumococcal Vaccine for Newborns

The current vaccine against bacterial pneumonia (pneumococcus) requires a regimen of four injections given at specific intervals. In developing countries, this not only complicates the vaccination process for health workers and children, but it also is a serious obstacle for families who must travel long distances to the nearest health clinic. Dr. Curtiss and his colleagues are working to develop new vaccines against bacterial pneumonia that require only a single dose, can be delivered orally, and are safe for newborns, infants, and people who are malnourished or whose immune systems are compromised.

Grant ID
OPP37863
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
14800000.00
Funding Currency
USD
Funding Amount (in USD)
14800000.00
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
14800000.00
Co-Funded
False